Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

ATTD: Advanced Technologies and Treatments for Diabetes

Early Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, ATTD 2025 Conference Catch-Up

20 Mar 2025

Description

In this episode of ATTD 2025 Conference Catch-Up, we dive into Early Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, featuring groundbreaking discussions on population-level screening, antibody detection, and strategies to implement early detection of Type 1 diabetes globally. Join us as we summarize key takeaways from these thought-provoking presentations: General Population Screening – Successes and Pitfalls – Dr. Anastasia Albanese-O’Neill Update on ADIR (Antibody Detection Israeli Research) Project – Prof. Moshe Phillip & Dr. Tal Oron Screening of Type 1 Diabetes and Celiac Disease of the General Pediatric Population in Italy: Progress and Preliminary Results – Prof. Emanuele Bosi EDENT1FI: Toward General Population Screening in Europe – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, diabetes researchers, public health professionals, and anyone involved in diabetes prevention, looking to stay updated on the latest advancements in early diagnosis and screening strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.